Michael L. Peterson, Director at TRXADE GROUP, INC. (MEDS), sold 900 shares at $4.68 ($4K) on 2021-04-19, disclosed to the SEC on 2021-04-20.
Scheduled sale ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PED | SELL | 2018-06-29 | $352K | — | Filing → |
| PED | SELL | 2017-12-29 | $8K | — | Filing → |
| PED | SELL | 2017-10-11 | $585 | — | Filing → |